Barriers and Facilitators for Smoking Cessation in Chinese Smokers with Chronic Obstructive Pulmonary Disease: A Qualitative Study
Ying-Ying Zhang,Wen-Tao Tang,Hong Zhang,Jing Wang,Xiao-Xu Bai,Yan-Hui Liao,Nicola Robinson,Jian-Ping Liu,Ying-Yng Zhang
DOI: https://doi.org/10.2147/COPD.S356935
2022-05-07
International Journal of COPD
Abstract:Ying-Ying Zhang, 1 Wen-Tao Tang, 2 Hong Zhang, 3 Jing Wang, 3 Xiao-Xu Bai, 3 Yan-Hui Liao, 4 Nicola Robinson, 1, 5 Jian-Ping Liu 1 1 Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China; 2 Pingyi Hospital of Traditional Chinese Medicine, Linyi, Shandong, People's Republic of China; 3 Fangshan Hospital of Traditional Chinese Medicine Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China; 4 Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, People's Republic of China; 5 Institute of Health and Social Care, London South Bank University, London, UK Correspondence: Jian-Ping Liu, Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Chaoyang District, Beijing, 100029, People's Republic of China, Email ; Background: Smoking cessation is recommended as a key intervention for chronic obstructive pulmonary disease (COPD) smokers. However, in China, few COPD smokers quit successfully. The aim of this study was to explore in depth the barriers and facilitators for smoking cessation among smokers with COPD in China. Methods: A purposive sample of 32 hospitalized smokers with COPD were included, 17 ex-smokers and 15 current smokers, participated in the semi-structured interviews. Interviews were analyzed thematically and using a deductive approach guided by Capability, Opportunity, Motivation-Behavior (COM-B) framework. Results: Three inter-related themes were generated: smokers' motivation was a prerequisite for quitting, maintaining capability to quit smoking, and opportunities that facilitated smokers to quit. Motivation to quit for most participants was activated by COPD-related symptoms, although they had a limited knowledge of COPD. Physical benefits from quitting and strong willpower were facilitators for maintaining quitting, while exposure to smoking environment and strong addiction to nicotine were frequent reasons for relapse. Most ex-smokers quit smoking by their own willpower rather than professionally delivered smoking cessation interventions. Smokers' attitudes toward these interventions depended on their effectiveness and convenience. Very few participants had experienced pharmacotherapy or behavioral support from physicians. However, interviewees preferred auricular acupressure to pharmacotherapy. Conclusion: Motivation to quit among smokers with COPD was usually initiated by COPD-related symptoms. Physical benefits observed by quitting and strong willpower facilitated smoking cessation, while exposure to smoking environment and strong addiction to nicotine led to relapse. COPD smokers in China preferred auricular acupressure to pharmacotherapy. Keywords: chronic obstructive pulmonary disease, smoking cessation, tobacco, qualitative research, acupuncture Smoking remains a global public health issue. More than 480,000 people die prematurely each year, and one-fifth of premature deaths are related to cigarette smoking. 1 Smoking is closely related to the occurrence and development of chronic obstructive pulmonary disease (COPD). 2 The GBD study in 2019 reported that of 369 diseases and injuries globally, COPD was the sixth leading cause of death and for people aged 50–74, COPD was the fourth most common cause of death. 3 Reports suggest that the prevalence of COPD is as high as 11.7% worldwide, and it is expected that this will be as high as 4.5 million people dying of COPD each year by 2030. 4 COPD is a chronic respiratory disease, mainly manifesting as recurrent cough, expectoration, breathlessness, chest tightness and wheezing. The pathological changes include chronic inflammation, with increased numbers of specific inflammatory cell types in the lung, and structural changes caused by repeated injury and repair. 5 Narrowing and inflammation of peripheral airways results in decreased FEV 1 6 , in addition to the narrowing of the airways, there is also a loss of small airways, and which may lead to airflow limitation. 7 This impacts significantly on patients' quality of life due to persistent symptoms or acute exacerbations. According to the pyramid of value for COPD interventions in the British Thoracic Society report in 2012, flu vaccination was considered as the most valuable therapy for patients at a risk of COPD. 8 However, for patients diagnosed with COPD, smoking is a major risk factor for COPD. 2 Smoking cessation in patients with COPD can effe -Abstract Truncated-